Patents
Literature
Eureka-AI is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Eureka AI

3319 results about "Saline water" patented technology

Saline water (more commonly known as salt water) is water that contains a high concentration of dissolved salts (mainly NaCl). The salt concentration is usually expressed in parts per thousand (permille, ‰) or parts per million (ppm). The United States Geological Survey classifies saline water in three salinity categories. Salt concentration in slightly saline water is around 1,000 to 3,000 ppm (0.1–0.3%), in moderately saline water 3,000 to 10,000 ppm (0.3–1%) and in highly saline water 10,000 to 35,000 ppm (1–3.5%). Seawater has a salinity of roughly 35,000 ppm, equivalent to 35 grams of salt per one liter (or kilogram) of water. The saturation level is dependent on the temperature of the water. At 20 °C one liter of water can dissolve about 357 grams of salt, a concentration of 26.3%. At boiling (100 °C) the amount that can be dissolved in one liter of water increases to about 391 grams, a concentration of 28.1%.

Dispensing and injection system for radiopharmaceuticals

InactiveUS20050203329A1Enhanced Radiation ProtectionEasy to effect automatic controlIn-vivo radioactive preparationsInfusion devicesSaline waterRadiation shield
Disclosed is a dispensing and injection system for radiopharmaceuticals, wherein a dosage calibrator is arranged inside a radiation-shielded hermetic chamber for detecting the radioactivity of radiopharmaceuticals contained in a vial. At least one saline water cartridge is arranged inside the casing and includes an internal passage, radiopharmaceuticals discharge end, a radiopharmaceuticals injection end, a and saline water reservoir outlet end. The saline water cartridge forms a saline water reservoir. A movable dispensing and injection mechanism controls radiopharmaceuticals dispensing operation of a syringe and controls movement of the syringe between a radiopharmaceuticals dispensing position and an injection position. When the movable dispensing and injection mechanism moves the syringe to the radiopharmaceuticals dispensing position, the syringe withdraws a predetermined amount of radiopharmaceuticals from the vial. When moved to the injection position, the syringe injects the withdrawn radiopharmaceuticals into the radiopharmaceuticals injection end of the saline water cartridge. After the radiopharmaceuticals is injected into a patient, the saline water stored in the saline water reservoir of the saline water cartridge is withdrawn for effecting flushing process.
Owner:SHIH CHI DAU

Method and apparatus for producting negative and positive oxidative reductive potential (orp) water

ActiveUS20050121334A1Effective and efficient and economicalCellsWater treatment parameter controlParticulatesElectrolysis
A method and apparatus for electrolytically producing oxidation reduction potential water from aqueous salt solutions for use in disinfection, sterilization, decontamination, wound cleansing. The apparatus includes an electrolysis unit having a three-compartment cell (22) comprising a cathode chamber (18), an anode chamber (16), and a saline solution chamber (20) interposed between the anode and cathod chambers. Two communicating (24, 26) membranes separate the three chambers. The center chamber includes a fluid flow inlet (21a) and outlet (21b) and contains insulative material that ensures direct voltage potential does not travel through the chamber. A supply of water flows through the cathode and anode chambers at the respective sides of the saline chamber. Saline solution flows through the center chamber, either by circulating a pre-prepared aqueous solution containing ionic species, or, alternatively, by circulating pure water or an aqueous solution of, e.g., aqueous hydrogen chloride and ammonium hydroxide, over particulate insulative material coated with a solid electrolyte. Electrical current is provided to the communicating membranes separating the chambers, thus causing an electrolytic reaction that produces both oxidative (positive) and reductive (negative) ORP water.
Owner:SONOMA PHARMA INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products